Synergistic effect of Pladienolide B and cisplatin: enhancing autophagy in hepatoma cells through the AMPK/mTOR/ULK1 pathway
Wei Xiao, Lei Yang, Ze Li, Wujie Wang, Zhaojian Liu, Bin Liu, Junchao Qin, Yuliang Li · 2026
Read Synergistic effect of Pladienolide B and cisplatin: enhancing autophagy in hepatoma cells through the AMPK/mTOR/ULK1 pathway by Wei Xiao, Lei Yang, Ze Li, Wujie Wang, Zhaojian Liu, Bin Liu, Junchao Qin, Yuliang Li (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13319244.txt.
Description
Wei Xiao and co-authors pair a splicing drug with classic chemotherapy against liver cancer cells, in a 2026 paper. The spliceosome part SF3B1 runs hot in hepatocellular carcinoma, and its blocker, Pladienolide B, already slows these cells and triggers their death. The team asked whether the pair beats either drug alone.
Gene readouts showed the splicing drug rewires alternative splicing and, through the AMPK-mTOR pathway, switches on autophagy, the cell's self-eating program. In mouse tumors, the combination shrank growth more than either treatment solo, cutting cell division, raising cell death, and boosting autophagy together. The authors pitch the pairing as a promising new line of attack on a stubborn cancer.
Catalog record
| CREATOR | Wei Xiao, Lei Yang, Ze Li, Wujie Wang, Zhaojian Liu, Bin Liu, Junchao Qin, Yuliang Li |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 54 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |